Maziere M., Farde L. and Maziere B. (1996) Preparation of 76Br-FLB 457 25.
and 76Br-FLB 463 for examination of striatal and extrastriatal dopamine
D-2 receptors with PET. Nucl. Med. Biol. 23, 813– 819.
18. Meltzer H. Y. (1992) The role of dopamine in schizophrenia. In: New
Biological Vistas on Schizophrenia (Edited by Lindenmayer J. -P. and Kay 26.
S. R.), pp. 131–157. Brunner/Mazel, New York.
19. Missale C., Russel Nash S., Robinson S. W., Jaber M. and Caron M. G.
(1998) Dopamine receptors: From structure to function. Physiol. Rev.
78, 189 –225.
27.
20. Mukherjee J., Yang Z.-Y., Das M. K. and Brown T. (1995) Fluorinated
benzamide neuroleptics-3. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[F-18]fluoropropyl)-2,3-dimethoxybenzamide as an
improved dopamine D-2 receptor tracer. Nucl. Med. Biol. 22, 283–296.
28.
21. Mukherjee J., Yang Z.-Y., Lew R., Brown T., Kronmal S., Cooper M. and
Seiden L. S. (1997) Evaluation of d-amphetamine effects on the binding of
dopamine D-2 receptor radioligand, [F-18]fallypride in non-human primates using positron emission tomography. Synapse 27, 1–13.
22. Munson P. J. and Rodbard D. (1980) LIGAND: A versatile approach 29.
for the characterisation of ligand binding systems. Anal. Biochem. 107,
220 –239.
23. Parsons B., Stanley M. and Javitch J. (1993) Differential visualization of
dopamine D2 and D3 receptors in rat brain. Eur. J. Pharmacol. 234, 30.
269 –272.
Sigmundson H. K. (1994) Pharmacotherapy of schizophrenia: A review.
Can. J. Psychiatry 39, 70 –75.
